The Latest Breaking News from SIGA Technologies

A former New York City official who helped coordinate the city’s response to the pandemic has been fired from his private-sector job

The healthcare industry is growing massively owing to new drugs and technological innovations. Thus, investing in fundamentally robust small-cap stocks Theratechnologies (THTX), Anika Therapeutics. (ANIK), and SIGA Technologies (SIGA) could be a good idea. Read more to find out….

New York-based pharmaceutical firm SIGA Technologies (NASDAQ: SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox.

SIGA Technologies Inc (NASDAQ: SIGA) shares are trading higher Monday morning following increased social media interest amid elevated concerns surrounding a monkeypox outbreak. 

 

The FDA approved the intravenous (IV) formulation of SIGA Technologies Inc's (NASDAQ:SIGA) TPOXX for smallpox. The oral formulation of TPOXX (tecovirimat) is approved in the US, Canada, and Europe to treat smallpox.  The European approval also includes the treatment of monkeypox, cowpox, and complications from immunization with vaccinia.  The IV formulation of TPOXX was…